The NMPA approval of the ZEISS CLARUS 700 represents a major leap forward in ultra-widefield retinal imaging, offering high-resolution, true color visualization to support early detection and management of complex eye diseases across China....
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....
The CE Mark approval of the VitalFlow™ ECMO System marks a significant advancement in extracorporeal life support, delivering enhanced precision and control for managing critically ill cardiac and respiratory patients....
World-first deployment of AI-powered laser tech enhances medication safety in high-risk hospital settings...
Highlighting key cybersecurity challenges and readiness gaps across the evolving medical device ecosystem....
CE Mark Approval Advances Precision Thrombectomy with Vessel-Conforming Design for Improved Stroke Outcomes Across Europe...
Next-gen GLP-1 therapies and real-time biosensors are redefining metabolic care—delivering effective weight loss while preserving muscle mass, and enabling more personalized, outcome-focused treatment. ...
New app rollout enhances insulin automation and real-time glucose monitoring through seamless smartphone control....
World Economic Forum recognizes INBRAIN for its groundbreaking graphene-based brain-computer interface platform aimed at treating neurological disorders with unmatched precision....
The first-in-human use of the Sola™ Coronary Laser IVL System marks a breakthrough in coronary calcium modification, providing physicians with a novel level of precision and control in treating complex calcified lesions....
